Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Mon, Mar 17th, 2025

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

2 Growth Stocks to Buy Now With 367% to 410% Upside

Strong, innovative pipelines make these two biotech firms smart buys now.

$SPX : 5,665.74 (+0.48%)
ARCT : 14.08 (unch)
PHAT : 4.56 (+3.40%)
Xeris Biopharma - Possibly the best Pharma Stock

Summary Xeris Biopharmaceuticals has shown strong technical buy signals, with a 30.03% gain since the Trend Seeker buy signal on 1/28. The company offers innovative therapies like Gvoke, Keveyis, and Recorlev,...

XERS : 4.86 (+0.83%)
2 ‘Strong Buy’ Stocks Under $10 Set to Surge as Much as 331%

These biotech companies are poised for significant long-term growth. However, there are risks.

$SPX : 5,665.74 (+0.48%)
STOK : 8.68 (+0.93%)
ACAD : 17.38 (-0.69%)
PHAT : 4.56 (+3.40%)
BIIB : 140.91 (+1.05%)
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street

These biotech companies’ strategic advancements are setting them up for long-term success.

RPRX : 32.79 (+0.06%)
JNJ : 162.98 (+0.10%)
VRTX : 509.43 (+0.92%)
SNDX : 12.91 (-0.31%)
ABBV : 212.66 (+0.42%)
GERN : 1.7100 (+4.27%)
RHHBY : 44.0700 (+1.87%)
PFE : 25.74 (+0.08%)
NTLA : 9.01 (-1.42%)
BMY : 58.94 (-0.12%)
BIIB : 140.91 (+1.05%)
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO?

This healthcare technology company is guiding for revenue growth of 150% for Q4.

BBNX : 15.30 (+4.26%)
Verona Pharma Keeps Hitting New Highs

Summary Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal. The company focuses on developing ensifentrine for respiratory...

VRNA : 62.75 (+2.22%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar